Susceptibility and adaptation to human TRIM5α alleles at positive selected sites in HIV-1 capsid

Virology

Volumn 441, Issue 2, 2013, Pages 162-170

  Rahm, Nadia ^a   Gfeller, David ^a,b   Snoeck, Joke ^a,c   Martinez, Raquel ^a   McLaren, Paul J ^a   Ortiz, Millán ^a   Ciuffi, Angela ^a   Telenti, Amalio ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Escape mutation; HIV 1 capsid; Positive selection; Restriction factor; TRIM5alpha

Indexed keywords

TRIPARTITE MOTIF PROTEIN 5;

ADAPTATION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; STRUCTURE ANALYSIS; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS STRAIN;

ADAPTATION, BIOLOGICAL; CARRIER PROTEINS; HIV CORE PROTEIN P24; HIV-1; HUMANS; SELECTION, GENETIC;

CERCOPITHECINE HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 84877920392     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.03.021     Document Type: Article

References (68)

1. Alter G., Heckerman D., Schneidewind A., Fadda L., Kadie C.M., Carlson J.M., Oniangue-Ndza C., Martin M., Li B., Khakoo S.I., Carrington M., Allen T.M., Altfeld M. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 2011, 476(7358):96-100.
2. Battivelli E., Lecossier D., Matsuoka S., Migraine J., Clavel F., Hance A.J. Strain-specific differences in the impact of human TRIM5alpha, different TRIM5alpha alleles, and the inhibition of capsid-cyclophilin A interactions on the infectivity of HIV-1. J. Virol. 2010, 84(21):11010-11019.
3. Battivelli E., Migraine J., Lecossier D., Yeni P., Clavel F., Hance A.J. Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5alpha, linking intrinsic and acquired immunity. J. Virol. 2011, 85(22):11846-11854.
4. Brockman M.A., Schneidewind A., Lahaie M., Schmidt A., Miura T., Desouza I., Ryvkin F., Derdeyn C.A., Allen S., Hunter E., Mulenga J., Goepfert P.A., Walker B.D., Allen T.M. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J. Virol. 2007, 81(22):12608-12618.
5. Fellay J., Shianna K.V., Ge D., Colombo S., Ledergerber B., Weale M., Zhang K., Gumbs C., Castagna A., Cossarizza A., Cozzi-Lepri A., De Luca A., Easterbrook P., Francioli P., Mallal S., Martinez-Picado J., Miro J.M., Obel N., Smith J.P., Wyniger J., Descombes P., Antonarakis S.E., Letvin N.L., McMichael A.J., Haynes B.F., Telenti A., Goldstein D.B. A whole-genome association study of major determinants for host control of HIV-1. Science 2007, 317(5840):944-947.
6. Gamble T.R., Vajdos F.F., Yoo S., Worthylake D.K., Houseweart M., Sundquist W.I., Hill C.P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 1996, 87(7):1285-1294.
7. Gamble T.R., Yoo S., Vajdos F.F., von Schwedler U.K., Worthylake D.K., Wang H., McCutcheon J.P., Sundquist W.I., Hill C.P. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 1997, 278(5339):849-853.
8. Ganser-Pornillos B.K., Chandrasekaran V., Pornillos O., Sodroski J.G., Sundquist W.I., Yeager M. Hexagonal assembly of a restricting TRIM5alpha protein. Proc. Natl. Acad. Sci. USA 2011, 108(2):534-539.
9. Ganser-Pornillos B.K., von Schwedler U.K., Stray K.M., Aiken C., Sundquist W.I. Assembly properties of the human immunodeficiency virus type 1 CA protein. J. Virol. 2004, 78(5):2545-2552.
10. Goldschmidt V., Bleiber G., May M., Martinez R., Ortiz M., Telenti A. Role of common human TRIM5alpha variants in HIV-1 disease progression. Retrovirology 2006, 3:54.
11. Goulder P.J., Watkins D.I. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat. Rev. Immunol. 2008, 8(8):619-630.
12. Hatziioannou T., Cowan S., Von Schwedler U.K., Sundquist W.I., Bieniasz P.D. Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J Virol 2004, 78(11):6005-6012.
13. Hatziioannou T., Perez-Caballero D., Yang A., Cowan S., Bieniasz P.D. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc. Natl. Acad. Sci. USA 2004, 101(29):10774-10779.
14. Henn M.R., Boutwell C.L., Charlebois P., Lennon N.J., Power K.A., Macalalad A.R., Berlin A.M., Malboeuf C.M., Ryan E.M., Gnerre S., Zody M.C., Erlich R.L., Green L.M., Berical A., Wang Y., Casali M., Streeck H., Bloom A.K., Dudek T., Tully D., Newman R., Axten K.L., Gladden A.D., Battis L., Kemper M., Zeng Q., Shea T.P., Gujja S., Zedlack C., Gasser O., Brander C., Hess C., Gunthard H.F., Brumme Z.L., Brumme C.J., Bazner S., Rychert J., Tinsley J.P., Mayer K.H., Rosenberg E., Pereyra F., Levin J.Z., Young S.K., Jessen H., Altfeld M., Birren B.W., Walker B.D., Allen T.M. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog. 2012, 8(3):e1002529.
15. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373(6510):123-126.
16. Holmes E.C. Error thresholds and the constraints to RNA virus evolution. Trends Microbiol. 2003, 11(12):543-546.
17. Ikeda Y., Ylinen L.M., Kahar-Bador M., Towers G.J. Influence of gag on human immunodeficiency virus type 1 species-specific tropism. J. Virol. 2004, 78(21):11816-11822.
18. Javanbakht H., An P., Gold B., Petersen D.C., O'Huigin C., Nelson G.W., O'Brien S.J., Kirk G.D., Detels R., Buchbinder S., Donfield S., Shulenin S., Song B., Perron M.J., Stremlau M., Sodroski J., Dean M., Winkler C. Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. Virology 2006, 354(1):15-27.
19. Kaumanns P., Hagmann I., Dittmar M.T. Human TRIM5alpha mediated restriction of different HIV-1 subtypes and Lv2 sensitive and insensitive HIV-2 variants. Retrovirology 2006, 3:79.
20. Kirmaier A., Wu F., Newman R.M., Hall L.R., Morgan J.S., O'Connor S., Marx P.A., Meythaler M., Goldstein S., Buckler-White A., Kaur A., Hirsch V.M., Johnson W.E. TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol. 2010, 8(8). e1000462.
21. Kono K., Song H., Yokoyama M., Sato H., Shioda T., Nakayama E.E. Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5alpha-mediated restriction. Retrovirology 2010, 7:72.
22. Kootstra N.A., Munk C., Tonnu N., Landau N.R., Verma I.M. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc. Natl. Acad. Sci. USA 2003, 100(3):1298-1303.
23. Kuroishi A., Saito A., Shingai Y., Shioda T., Nomaguchi M., Adachi A., Akari H., Nakayama E.E. Modification of a loop sequence between alpha-helices 6 and 7 of virus capsid (CA) protein in a human immunodeficiency virus type 1 (HIV-1) derivative that has simian immunodeficiency virus (SIVmac239) vif and CA alpha-helices 4 and 5 loop improves replication in cynomolgus monkey cells. Retrovirology 2009, 6:70.
24. Lassaux A., Sitbon M., Battini J.L. Residues in the murine leukemia virus capsid that differentially govern resistance to mouse Fv1 and human Ref1 restrictions. J. Virol. 2005, 79(10):6560-6564.
25. Letvin N.L., Rao S.S., Montefiori D.C., Seaman M.S., Sun Y., Lim S.Y., Yeh W.W., Asmal M., Gelman R.S., Shen L., Whitney J.B., Seoighe C., Lacerda M., Keating S., Norris P.J., Hudgens M.G., Gilbert P.B., Buzby A.P., Mach L.V., Zhang J., Balachandran H., Shaw G.M., Schmidt S.D., Todd J.P., Dodson A., Mascola J.R., Nabel G.J. Immune and genetic correlates of vaccine protection against mucosal infection by SIV in monkeys. Sci. Transl. Med. 2011, 3(81):81ra36.
26. Li X., Gold B., O'HUigin C., Diaz-Griffero F., Song B., Si Z., Li Y., Yuan W., Stremlau M., Mische C., Javanbakht H., Scally M., Winkler C., Dean M., Sodroski J. Unique features of TRIM5alpha among closely related human TRIM family members. Virology 2007, 360(2):419-433.
27. Li Y., Li X., Stremlau M., Lee M., Sodroski J. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection. J. Virol. 2006, 80(14):6738-6744.
28. Lim S.Y., Rogers T., Chan T., Whitney J.B., Kim J., Sodroski J., Letvin N.L. TRIM5alpha modulates immunodeficiency virus control in rhesus monkeys. PLoS Pathog. 2010, 6(1):e1000738.
29. Liu F.L., Qiu Y.Q., Li H., Kuang Y.Q., Tang X., Cao G., Tang N.L., Zheng Y.T. An HIV-1 resistance polymorphism in TRIM5alpha gene among Chinese intravenous drug users. J. Acquir. Immune Defic. Syndr. 2011, 56(4):306-311.
30. Luban J. Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. J. Virol. 2007, 81(3):1054-1061.
31. Maillard P.V., Reynard S., Serhan F., Turelli P., Trono D. Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha. PLoS Pathog. 2007, 3(12):e200.
32. Maillard P.V., Zoete V., Michielin O., Trono D. Homology-based identification of capsid determinants that protect HIV1 from human TRIM5alpha restriction. J. Biol. Chem. 2011, 286(10):8128-8140.
33. Mansky L.M. Retrovirus mutation rates and their role in genetic variation. J. Gen. Virol. 1998, 79(Pt 6):1337-1345.
34. Martinez-Picado J., Prado J.G., Fry E.E., Pfafferott K., Leslie A., Chetty S., Thobakgale C., Honeyborne I., Crawford H., Matthews P., Pillay T., Rousseau C., Mullins J.I., Brander C., Walker B.D., Stuart D.I., Kiepiela P., Goulder P. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 2006, 80(7):3617-3623.
35. Meddows-Taylor S., Papathanasopoulos M.A., Kuhn L., Meyers T.M., Tiemessen C.T. Detection of human immunodeficiency virus type 1 envelope peptide-stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children. Virus Genes 2004, 28(3):311-318.
36. Nakajima T., Nakayama E.E., Kaur G., Terunuma H., Mimaya J.I., Ohtani H., Mehra N., Shioda T., Kimura A. Impact of novel TRIM5alpha variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection. AIDS 2009, 23(16):2091-2100.
37. Newman R.M., Hall L., Connole M., Chen G.L., Sato S., Yuste E., Diehl W., Hunter E., Kaur A., Miller G.M., Johnson W.E. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha. Proc. Natl. Acad. Sci. USA 2006, 103(50):19134-19139.
38. Ohkura S., Goldstone D.C., Yap M.W., Holden-Dye K., Taylor I.A., Stoye J.P. Novel escape mutants suggest an extensive TRIM5alpha binding site spanning the entire outer surface of the murine leukemia virus capsid protein. PLoS Pathog. 2011, 7(3):e1002011.
39. Owens C.M., Song B., Perron M.J., Yang P.C., Stremlau M., Sodroski J. Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid. J. Virol. 2004, 78(10):5423-5437.
40. Owens C.M., Yang P.C., Gottlinger H., Sodroski J. Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells. J Virol 2003, 77(1):726-731.
41. Pacheco B., Finzi A., Stremlau M., Sodroski J. Adaptation of HIV-1 to cells expressing rhesus monkey TRIM5alpha. Virology 2010, 408(2):204-212.
42. Paul S., Piontkivska H. Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs. BMC Microbiol. 2010, 10:212.
43. Pereyra F., Jia X., McLaren P.J., Telenti A., de Bakker P.I., Walker B.D., The International HIV Controllers Study The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010, 330(6010):1551-1557.
44. Pham Q.T., Bouchard A., Grutter M.G., Berthoux L. Generation of human TRIM5alpha mutants with high HIV-1 restriction activity. Gene Ther. 2010, 17(7):859-871.
45. Pornillos O., Ganser-Pornillos B.K., Kelly B.N., Hua Y., Whitby F.G., Stout C.D., Sundquist W.I., Hill C.P., Yeager M. X-ray structures of the hexameric building block of the HIV capsid. Cell 2009, 137(7):1282-1292.
46. Price H., Lacap P., Tuff J., Wachihi C., Kimani J., Ball T.B., Luo M., Plummer F.A. A TRIM5alpha exon 2 polymorphism is associated with protection from HIV-1 infection in the Pumwani sex worker cohort. AIDS 2010, 24(12):1813-1821.
47. Rahm N., Telenti A. The role of tripartite motif family members in mediating susceptibility to HIV-1 infection. Curr. Opin. HIV AIDS 2012.
48. Rahm N., Yap M., Snoeck J., Zoete V., Munoz M., Radespiel U., Zimmermann E., Michielin O., Stoye J.P., Ciuffi A., Telenti A. Unique spectrum of activity of prosimian TRIM5alpha against exogenous and endogenous retroviruses. J. Virol. 2011, 85(9):4173-4183.
49. Rambaut A., Posada D., Crandall K.A., Holmes E.C. The causes and consequences of HIV evolution. Nat. Rev. Genet. 2004, 5(1):52-61.
50. Richardson M.W., Carroll R.G., Stremlau M., Korokhov N., Humeau L.M., Silvestri G., Sodroski J., Riley J.L. Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha. J. Virol. 2008, 82(22):11117-11128.
51. Richman D.D., Wrin T., Little S.J., Petropoulos C.J. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. USA 2003, 100(7):4144-4149.
52. Sanjuan R., Borderia A.V. Interplay between RNA structure and protein evolution in HIV-1. Mol. Biol. Evol. 2011, 28(4):1333-1338.
53. Sawyer S.L., Wu L.I., Akey J.M., Emerman M., Malik H.S. High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5alpha in humans. Curr. Biol. 2006, 16(1):95-100.
54. Sebastian S., Sokolskaja E., Luban J. Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent manner. J. Virol. 2006, 80(4):2051-2054.
55. Shi J., Aiken C. Saturation of TRIM5 alpha-mediated restriction of HIV-1 infection depends on the stability of the incoming viral capsid. Virology 2006, 350(2):493-500.
56. Snoeck J., Fellay J., Bartha I., Douek D.C., Telenti A. Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints. Retrovirology 2011, 8:87.
57. Sokolskaja E., Berthoux L., Luban J. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells. J. Virol. 2006, 80(6):2855-2862.
58. Song B., Javanbakht H., Perron M., Park D.H., Stremlau M., Sodroski J. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. J. Virol. 2005, 79(7):3930-3937.
59. Speelmon E.C., Livingston-Rosanoff D., Li S.S., Vu Q., Bui J., Geraghty D.E., Zhao L.P., McElrath M.J. Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection. J. Virol. 2006, 80(5):2463-2471.
60. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427(6977):848-853.
61. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427(6977):848-853.
62. Telenti A. Adaptation, co-evolution, and human susceptibility to HIV-1 infection. Infect. Genet. Evol. 2005, 5(4):327-334.
63. van Manen D., Rits M.A., Beugeling C., van Dort K., Schuitemaker H., Kootstra N.A. The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection. PLoS Pathog. 2008, 4(2):e18.
64. Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S., Komarova N.L., Nowak M.A., Hahn B.H., Kwong P.D., Shaw G.M. Antibody neutralization and escape by HIV-1. Nature 2003, 422(6929):307-312.
65. Woo J., Robertson D.L., Lovell S.C. Constraints on HIV-1 diversity from protein structure. J. Virol. 2010, 84(24):12995-13003.
66. Ylinen L.M., Keckesova Z., Wilson S.J., Ranasinghe S., Towers G.J. Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles. J. Virol. 2005, 79(18):11580-11587.
67. Zhao G., Ke D., Vu T., Ahn J., Shah V.B., Yang R., Aiken C., Charlton L.M., Gronenborn A.M., Zhang P. Rhesus TRIM5alpha disrupts the HIV-1 capsid at the inter-hexamer interfaces. PLoS Pathog. 2011, 7(3):e1002009.
68. Zhuang J., Jetzt A.E., Sun G., Yu H., Klarmann G., Ron Y., Preston B.D., Dougherty J.P. Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J. Virol. 2002, 76(22):11273-11282.